Stentys Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • 2PO

  • Latest Deal Amount
  • $13.9M

  • Investors
  • 1

Stentys General Information

Description

Stentys is engaged in designing, developing, and marketing self-expanding stents used in treating cardiovascular diseases in the treatment of patients with acute myocardial infarction and other complex coronary diseases. Its products include xpositions, mistent, stentys btk, stentys ac, and stentys stent.

Contact Information

Website
www.stentys.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 17-19 avenue de la Métallurgie
  • 93210 Saint Denis
  • France
+33 01
Primary Industry
Surgical Devices
Corporate Office
  • 17-19 avenue de la Métallurgie
  • 93210 Saint Denis
  • France
+33 01

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stentys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. 2PO 07-Mar-2016 $13.9M Completed Generating Revenue
5. PIPE 14-May-2014 Completed Generating Revenue
4. IPO 02-Aug-2013 Completed Generating Revenue
3. Early Stage VC (Series B) 25-Jun-2009 Completed Generating Revenue
2. Early Stage VC (Series B) 31-Mar-2008 $18M $22M Completed Generating Revenue
1. Early Stage VC (Series A) $4.03M Completed Generating Revenue
To view Stentys’s complete valuation and funding history, request access »

Stentys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stentys Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Societe Generale Investment Bank Minority
To view Stentys’s complete investors history, request access »

Stentys Acquisitions (2)

Stentys’s most recent deal was a Merger/Acquisition with Minvasys for . The deal was made on 30-Apr-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Minvasys 30-Apr-2018 Merger/Acquisition Surgical Devices
Cappella Peel Away 04-Jun-2014 Merger/Acquisition Biotechnology
To view Stentys’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Stentys ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Stentys’s complete esg history, request access »

Stentys Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Minvasys Gennevilliers, France 2003

Stentys FAQs

  • When was Stentys founded?

    Stentys was founded in 2006.

  • Where is Stentys headquartered?

    Stentys is headquartered in Saint Denis, France.

  • What is the size of Stentys?

    Stentys has 26 total employees.

  • What industry is Stentys in?

    Stentys’s primary industry is Surgical Devices.

  • Is Stentys a private or public company?

    Stentys is a Private company.

  • What is Stentys’s current revenue?

    The current revenue for Stentys is .

  • How much funding has Stentys raised over time?

    Stentys has raised $87.9M.

  • Who are Stentys’s investors?

    Societe Generale has invested in Stentys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »